跳至主要内容
临床试验/NCT04575545
NCT04575545Unknown不适用

Prevalence of COVID-19 Infection in a Cohort of Patient Infected by the HIV and Patients Taking PrEP Pre-exposure Prophylaxis

Hôpital Européen Marseille1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2020年10月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
600
试验地点
1
主要终点
% of patients with positive serological tests for covid-19

研究概览

简要总结

The purpose of the study is to assess seroprevalence of COVID-19 infection in a cohort of HIV + patients and in a cohort of patients taking PrEP by emtricitabine / tenofovir.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged ≥ 18 years
  • patients infected by the HIV on treatment
  • patients taking PreP (Pre-exposure prophylaxis (PrEP))
  • Being affiliated with or benefiting from a social security scheme

排除标准

  • Subject to a measure for the protection of justice

结局指标

主要结局

% of patients with positive serological tests for covid-19

时间窗: 3 months

次要结局

  • Presence and quantification of CD4 / CD8 reactivity to COVID-19 epitopes in patient with positive and negative serological tests for covid-19(3 months)

研究者

发起方
Hôpital Européen Marseille
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验